CommercialCoverageMedium impact
Revised Medical Policies
EmblemHealth·Oncology, OB-GYN, Sleep Medicine +1 more·Provider News
We identified it
Jun 20, 2026
Summary
EmblemHealth has revised three medical policies covering Gene Expression Profiling and Biomarker Testing for Breast Cancer, Obstructive Sleep Apnea Diagnosis and Treatment (for both EmblemHealth and ConnectiCare), and Recurrent Pregnancy Loss. These revisions may affect coverage criteria, prior authorization requirements, or documentation standards for these specific conditions.
Action Required
Immediately: Review the updated EmblemHealth policy documents at https://www.emblemhealth.com/providers/news/revised-medical-policies to identify specific changes to coverage criteria, prior authorization requirements, and documentation standards for breast cancer biomarker testing, sleep apnea services, and recurrent pregnancy loss treatments. Update billing workflows and staff training accordingly based on the specific revisions found in each policy.